How To Deal With Colon Cancer
One of the many aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in it’s late stages at which time it is more difficult to make treatments.
As the symptoms of neuroendocrine colon cancer become visible only in the most advanced stages the chances of survival drops at an alarming rate. The polyps or tumors of the colon are malignant and are usually detected with distant metastases. Most recent surveys show that reports reveal that in almost all cases of neuroendocrine cancer result in death.
Though chances of neuroendocrine carcinoma in colon are extremely unlikely, if one is affected the health of the patient appears even worse than patients who suffer from adenocarcinoma.
Research shows that the end results of this form of cancer do not change with age, sex or tumor location. Though neuroendocrine colon carcinoma will depend heavily on the tumor’s stage. The usual trends have revealed that people in stage 1 and 2 of cancer will generally not experience neuroendocrine colon cancer. But alternately in many cases if the tumor is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. this method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and in a certain study in which a number of patients suffered from this particular disease underwent examination and, it was noted that the overall survival rate for this disease was only about seven months. In the later stages these rates decrease, to as low as five months or less. The great majority of these cases were originally seen as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery is not always a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to notice the presence of this disease quickly and prescribe the right medication.
